Structures by: Sha Y.
Total: 11
C11H10CuO7
C11H10CuO7
Dalton transactions (Cambridge, England : 2003) (2016) 45, 17 7235-7239
a=18.4978(19)Å b=18.4978(19)Å c=6.7746(7)Å
α=90° β=90° γ=120°
(S)-2,3,5,10,11,11a-Hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione
C12H12N2O2
Acta Crystallographica Section E (2007) 63, 12 o4605-o4605
a=16.280(2)Å b=6.2848(9)Å c=11.1016(15)Å
α=90.00° β=112.810(2)° γ=90.00°
(11aS)-8-Hydroxy-7-methoxy-2,3,5,10,11,11a-hexahydro-1H- pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione
C13H14N2O4
Acta Crystallographica Section E (2008) 64, 1 o266-o266
a=6.3819(7)Å b=9.3139(10)Å c=10.3673(11)Å
α=90.00° β=103.6210(10)° γ=90.00°
(<i>S</i>)-Ethyl 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylate
C14H16N2O2
Acta Crystallographica Section E (2008) 64, 5 o815
a=6.0545(8)Å b=9.1438(13)Å c=11.5228(16)Å
α=90.00° β=92.905(2)° γ=90.00°
[(3a<i>S</i>,5a<i>R</i>,8a<i>R</i>,8b<i>S</i>)-2,2,7,7-Tetramethyltetrahydro- 3a<i>H</i>-bis[1,3]dioxolo[4,5-<i>b</i>:4',5'-<i>d</i>]pyran-3a-yl]methyl (<i>R</i>)-<i>N</i>-(1-phenylethyl)sulfamate
C20H29NO8S
Acta Crystallographica Section E (2012) 68, 5 o1581
a=9.5733(9)Å b=15.0134(14)Å c=15.9462(15)Å
α=90.00° β=90.00° γ=90.00°
C16H22Co,F6P
C16H22Co,F6P
Journal of the American Chemical Society (2019)
a=6.5974(2)Å b=15.3006(5)Å c=16.7260(6)Å
α=90° β=90° γ=90°
C10H10CoF6P
C10H10CoF6P
Journal of the American Chemical Society (2019)
a=13.2837(17)Å b=9.1759(12)Å c=9.2520(12)Å
α=90° β=96.293(3)° γ=90°
C14H18Co,F6P
C14H18Co,F6P
Journal of the American Chemical Society (2019)
a=10.8185(3)Å b=10.8185(3)Å c=6.6735(2)Å
α=90° β=90° γ=90°
C18H26Co,F6P
C18H26Co,F6P
Journal of the American Chemical Society (2019)
a=11.6313(4)Å b=9.8968(4)Å c=8.6586(3)Å
α=90° β=105.259(2)° γ=90°
C26H42Co,1(F6P)
C26H42Co,1(F6P)
Journal of the American Chemical Society (2019)
a=10.1801(5)Å b=25.8207(13)Å c=11.3019(6)Å
α=90° β=112.920(2)° γ=90°
C18H26Co,F6P
C18H26Co,F6P
Journal of the American Chemical Society (2019)
a=13.1710(4)Å b=11.3315(4)Å c=12.6496(4)Å
α=90° β=90° γ=90°